Literature DB >> 7556648

Concomitant expression of hepatocyte growth factor (HGF), HGF activator and c-met genes in human glioma cells in vitro.

T Moriyama1, H Kataoka, H Tsubouchi, M Koono.   

Abstract

Three new cell lines of human glioblastoma have been established. These cells co-expressed hepatocyte growth factor (HGF) and its receptor, c-Met, genes in vitro. Reverse-transcriptase/polymerase-chain reaction study revealed that the cells also expressed gene for HGF activator, a recently cloned serine proteinase, suggesting that HGF might have a role in glioma cells in vitro as an autocrine factor. The activator mRNA was also detected in other well-established glioma cell lines, glioma tissues and normal brain. The concomitant expression of HGF, HGF activator and c-met was also detected in one glioblastoma case in vivo out of five tested.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7556648     DOI: 10.1016/0014-5793(95)00949-a

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

Review 1.  Hepatocyte growth factor/scatter factor-induced intracellular signalling.

Authors:  K A Stuart; S M Riordan; S Lidder; L Crostella; R Williams; G G Skouteris
Journal:  Int J Exp Pathol       Date:  2000-02       Impact factor: 1.925

2.  Scatter factor/hepatocyte growth factor stimulation of glioblastoma cell cycle progression through G(1) is c-Myc dependent and independent of p27 suppression, Cdk2 activation, or E2F1-dependent transcription.

Authors:  Kevin A Walter; Mir Ahamed Hossain; Carey Luddy; Nidhi Goel; Thomas E Reznik; John Laterra
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

3.  Establishment and characterization of a new human glioblastoma cell line, NYGM.

Authors:  Yoshitsugu Nuki; Shunro Uchinokura; Shiro Miyata; Tsuyoshi Fukushima; Ryouichi Hamasuna; Shinichi Nakano; Shinichiro Wakisaka; Yutaka Akiyama; Hiroshi Itoh; Hiroaki Kataoka
Journal:  Hum Cell       Date:  2004-09       Impact factor: 4.174

4.  Simultaneous up-regulation of urokinase-type plasminogen activator (uPA) and uPA receptor by hepatocyte growth factor/scatter factor in human glioma cells.

Authors:  T Moriyama; H Kataoka; R Hamasuna; E Yoshida; T Sameshima; T Iseda; K Yokogami; S Nakano; M Koono; S Wakisaka
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

5.  Roles of Kunitz domains in the anti-invasive effect of hepatocyte growth factor activator inhibitor type 1 in human glioblastoma cells.

Authors:  Shiro Miyata; Tsuyoshi Fukushima; Kazuyo Kohama; Hiroyuki Tanaka; Hideo Takeshima; Hiroaki Kataoka
Journal:  Hum Cell       Date:  2007-11       Impact factor: 4.174

Review 6.  MET: a promising anticancer therapeutic target.

Authors:  Solange Peters; Alex A Adjei
Journal:  Nat Rev Clin Oncol       Date:  2012-05-08       Impact factor: 66.675

7.  c-KIT and c-KIT ligand (SCF) in synovial sarcoma (SS): an mRNA expression analysis in 23 cases.

Authors:  E Tamborini; D Papini; A Mezzelani; C Riva; A Azzarelli; G Sozzi; M A Pierotti; S Pilotti
Journal:  Br J Cancer       Date:  2001-08-03       Impact factor: 7.640

Review 8.  Mechanisms of hepatocyte growth factor activation in cancer tissues.

Authors:  Makiko Kawaguchi; Hiroaki Kataoka
Journal:  Cancers (Basel)       Date:  2014-09-29       Impact factor: 6.639

Review 9.  Role of cancer cell-stroma interaction in invasive growth of cancer cells.

Authors:  Hiroaki Kataoka; Hiroyuki Tanaka; Koki Nagaike; Shuichiro Uchiyama; Hiroshi Itoh
Journal:  Hum Cell       Date:  2003-03       Impact factor: 4.374

10.  Epigenetic Silencing of SPINT2 Promotes Cancer Cell Motility via HGF-MET Pathway Activation in Melanoma.

Authors:  Soonyean Hwang; Hye-Eun Kim; Michelle Min; Rekha Raghunathan; Izabela P Panova; Ruchi Munshi; Byungwoo Ryu
Journal:  J Invest Dermatol       Date:  2015-04-24       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.